Sleep disturbances in systemic sclerosis: Evidence for the role of gastrointestinal symptoms, pain and pruritus

Rheumatology (United Kingdom)

Volumn 52, Issue 9, 2013, Pages 1715-1720

  Milette, Katherine ^a,b   Hudson, Marie ^a,b   Körner, Annett ^a,b   Baron, Murray ^a,b   Thombs, Brett D ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Gastrointestinal symptoms; Pain; Pruritus; Scleroderma; Sleep; Systemic sclerosis

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ARTICLE; CHARLSON COMORBIDITY INDEX; CLINICAL EVALUATION; CONVERGENT VALIDITY; DEPRESSION; DISEASE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; DYSPNEA; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MCGILL PAIN QUESTIONNAIRE; MEASUREMENT PRECISION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SELF REPORT; SKIN PAIN; SKIN PRURITUS; SLEEP DISORDER; SLEEP QUALITY; SYSTEMIC SCLEROSIS;

GASTROINTESTINAL SYMPTOMS; PAIN; PRURITUS; SCLERODERMA; SLEEP; SYSTEMIC SCLEROSIS;

ADULT; AGED; DEPRESSION; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MIDDLE AGED; PAIN; PRURITUS; QUALITY OF LIFE; REGISTRIES; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS; SMOKING;

EID: 84883017097     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket223     Document Type: Article

References (32)

1. Mayes MD. Systemic sclerosis: A? Clinical features. In: Klippel J, Stone J, Crafford L, White P, eds. Primer on the rheumatic diseases. New York, NY: Springer and Arthritis Foundation, 2008343-50.
2. Seibold J, Harris E, Budd R et al., eds., Kelley's textbook of rheumatology. Philadelphia, PA: Elsevier, 2005.
3. Prado GF, Allen RP, Trevisani VM et al. Sleep disruption in systemic sclerosis (scleroderma) patients: clinical and polysomnographic findings. Sleep Med 20023:341-5.
4. Milette K, Razykov I, Pope J et al. Clinical correlates of sleep problems in systemic sclerosis: the prominent role of pain. Rheumatology 201150:921-5.
5. Frech T, Hays RD, Maranian P et al. Prevalence and correlates of sleep disturbance in systemic sclerosis-results from the UCLA scleroderma quality of life study. Rheumatology 201150:1280-7.
6. Bassel M, Hudson M, Taillefer SS et al. Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey. Rheumatology 201150:762-7.
7. National Institutes of Health. National Institutes of Health state of the science conference statement. Manifestations and management of chronic insomnia in adults June 13-15, 2005. Sleep 200528:1049-57.
8. Abad VC, Sarinas PSA, Guilleminault C. Sleep and rheumatologic disorders. Sleep Med Rev 200812:211-28.
9. Razykov I, Thombs BD, Hudson M et al. The Canadian Scleroderma Research Group. Prevalence and clinical correlates of pruritus in patients with systemic sclerosis. Arthritis Care Res 200961:1765-70.
10. Szepietowski JC, Reich A. Quality of life and pruritus? In: Preedy VR, Watson RR, eds. Handbook of disease burdens and quality of life measures. New York, NY: Springer, 20102151-62.
11. Gowda S, Goldblum OM, McCall WV et al. Factors affecting sleep quality in patients with psoriasis. J Am Acad Dermatol 201063:114-23.
12. Thorburn PT, Riha RL. Skin disorders and sleep in adults: where is the evidence? Sleep Med Rev 201014:351-8.
13. Yu L, Buysse DJ, Germain A et al. Development of short forms from the PROMIS sleep disturbance and sleeprelated impairment item banks. Behav Sleep Med 201110: 6-24.
14. LeRoy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 198815:202-5.
15. Clements P, Lachenbruch P, Siebold J et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 199522:1281-5.
16. Prevoo MLL, Van'T Hof MA, Kuper HH et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 199538:44-8.
17. Steen VD, Medsger TA. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 199740:1984-91.
18. Phan NQ, Blome C, Fritz F et al. Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus. Acta Derm Venereol 201292:502-7.
19. Katz JN, Chang LC, Sangha O et al. Can comorbidity be measured by questionnaire rather than medical record review? Med Care 199634:73-84.
20. Schieir O, Thombs BD, Hudson M et al. Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis. Arthritis Care Res 201062:409-17.
21. Jensen MP, Karoly P, Braver S. The measurement of clinical pain intensity: a comparison of six methods. Pain 198627:117-26.
22. El-Baalbaki G, Lober J, Hudson M et al. Measuring pain in systemic sclerosis: comparison of the short-form McGill Pain Questionnaire versus a single-item measure of pain. J Rheumatol 201138:2581-7.
23. Chow E, Doyle M, Li K et al. Mild, moderate, or severe pain categorized by patients with cancer with bone metastases. J Palliat Med 20069:850-4.
24. Salaffi F, Stancati A, Silvestri CA et al. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain 20048:283-91.
25. Thombs BD, Hudson M, Schieir O et al. Reliability and validity of the Center for Epidemiologic Studies Depression Scale in patients with systemic sclerosis. Arthritis Rheum 200859:438-43.
26. Ikoma A, Rukwied R, Stander S et al. Neurophysiology of pruritus: interaction of itch and pain. Arch Dermatol 2003139: 1475-8.
27. Krajnik MÇ, Zylicz Z. Understanding pruritus in systemic disease. J Pain Symptom Manag 200121:151-68.
28. Yosipovitch G, Carstens E, McGlone F. Chronic itch and chronic pain: analogous mechanisms. Pain 2007131:4-7.
29. Thombs BD, Hudson M, Bassel M et al. Canadian Scleroderma Research Group. Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: evidence from a sample of 659 Canadian Scleroderma Research Group Registry patients. Arthritis Care Res 200961:966-73.
30. Levis B, Hudson M, Knafo R et al. Rates and correlates of sexual activity and impairment among women with systemic sclerosis. Arthritis Care Res 201264:340-50.
31. Gyger G, Baron M. Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management. Curr Rheumatol Rep 201214:22-9.
32. Aktas A, Walsh D, Rybicki L. Symptom clusters: myth or reality? Palliat Med 201024:373-85.